Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients/Experiment 1/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/19

Curator: Joiejoie

Revision editor(s): Joiejoie

Source: Figure S2D

Description: This figure highlights the microbial taxa dynamics associated with treatment response, emphasizing the potential role of specific gut microbiota in influencing clinical outcomes during anti-PD-1 therapy.

Abundance in Group 1: increased abundance in complete responders (CR)

NCBI	Quality Control	Links
Candidatus_Roslinia_caecaviumCandidatus_Roslinia_caecavium
Candidatus_Metaruminococcus_gallistercorisCandidatus_Metaruminococcus_gallistercoris
Candidatus_Metalachnospira_gallinarumCandidatus_Metalachnospira_gallinarum
Candidatus_Gallimonas_caecicolaCandidatus_Gallimonas_caecicola
Candidatus_Heteroscilispira_lomaniiCandidatus_Heteroscilispira_lomanii
f_Veillonellaceae_SGB5809_groupf_Veillonellaceae_SGB5809_group
Bacteroides_nordiiBacteroides_nordii
Bifidobacterium_pseodolongumBifidobacterium_pseodolongum
Bifidobacterium_pullorumBifidobacterium_pullorum

Revision editor(s): Joiejoie